Global Acute Myeloid Leukemia Therapeutics Databank Market Report

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,000	100 Pages	Magna Intelligence	April, 2024	MAIN18740240

Best Price Guarantee
Price	from $2,000
Length	100 Pages
Publisher	Magna Intelligence
Published Date	April, 2024
SKU	MAIN18740240

Global Acute Myeloid Leukemia Therapeutics Databank Market Report

The Acute Myeloid Leukemia Therapeutics market was valued at $8,798.5 Million in 2022, and is projected to reach $13,821.6 Million by 2031 growing at a CAGR of 5.19% from 2023 to 2031. Targeted Therapy and Immunotherapy segment is expected to be the highest contributor to this market, with $5,909.9 Million in 2022, and is anticipated to reach $8,938.5 Million by 2031, registering a CAGR of 4.75%. Chemotherapy segment is anticipated to reach $4,883.0 Million by 2031 with the highest CAGR of 6.05%.

1. Global Acute Myeloid Leukemia Therapeutics Market, By Drug Class: 1.1. Overview; 1.2. Chemotherapy; 1.2.1 Chemotherapy Market, By Region; 1.2.1.1 North America Chemotherapy Market, By Country; 1.2.1.2 Europe Chemotherapy Market, By Country; 1.2.1.3 Asia-Pacific Chemotherapy Market, By Country; 1.2.1.4 Rest of World Chemotherapy Market, By Country; 1.3. Targeted Therapy and Immunotherapy; 1.3.1 Targeted Therapy and Immunotherapy Market, By Region; 1.3.1.1 North America Targeted Therapy and Immunotherapy Market, By Country; 1.3.1.2 Europe Targeted Therapy and Immunotherapy Market, By Country; 1.3.1.3 Asia-Pacific Targeted Therapy and Immunotherapy Market, By Country; 1.3.1.4 Rest of World Targeted Therapy and Immunotherapy Market, By Country
2. Global Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel: 2.1. Overview; 2.2. Hospital Pharmacies; 2.2.1 Hospital Pharmacies Market, By Region; 2.2.1.1 North America Hospital Pharmacies Market, By Country; 2.2.1.2 Europe Hospital Pharmacies Market, By Country; 2.2.1.3 Asia-Pacific Hospital Pharmacies Market, By Country; 2.2.1.4 Rest of World Hospital Pharmacies Market, By Country; 2.3. Drug Stores and Retail Pharmacies; 2.3.1 Drug Stores and Retail Pharmacies Market, By Region; 2.3.1.1 North America Drug Stores and Retail Pharmacies Market, By Country; 2.3.1.2 Europe Drug Stores and Retail Pharmacies Market, By Country; 2.3.1.3 Asia-Pacific Drug Stores and Retail Pharmacies Market, By Country; 2.3.1.4 Rest of World Drug Stores and Retail Pharmacies Market, By Country; 2.4. Online Provides; 2.4.1 Online Provides Market, By Region; 2.4.1.1 North America Online Provides Market, By Country; 2.4.1.2 Europe Online Provides Market, By Country; 2.4.1.3 Asia-Pacific Online Provides Market, By Country; 2.4.1.4 Rest of World Online Provides Market, By Country
3. Global Acute Myeloid Leukemia Therapeutics Market, By Region: 3.1. Overview; 3.2. North America; 3.2.1 North America Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.2.2 North America Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.2.3 North America Acute Myeloid Leukemia Therapeutics Market, By Country; 3.2.3.1 U.S.; 3.2.3.1.1 U.S. Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.2.3.1.2 U.S. Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.2.3.2 Canada; 3.2.3.2.1 Canada Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.2.3.2.2 Canada Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.3. Europe; 3.3.1 Europe Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.3.2 Europe Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.3.3 Europe Acute Myeloid Leukemia Therapeutics Market, By Country; 3.3.3.1 Germany; 3.3.3.1.1 Germany Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.3.3.1.2 Germany Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.3.3.2 U.K.; 3.3.3.2.1 U.K. Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.3.3.2.2 U.K. Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.3.3.3 France; 3.3.3.3.1 France Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.3.3.3.2 France Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.3.3.4 Italy; 3.3.3.4.1 Italy Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.3.3.4.2 Italy Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.3.3.5 Spain; 3.3.3.5.1 Spain Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.3.3.5.2 Spain Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.3.3.6 Rest of Europe; 3.3.3.6.1 Rest of Europe Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.3.3.6.2 Rest of Europe Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.4. Asia-Pacific; 3.4.1 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.4.2 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.4.3 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market, By Country; 3.4.3.1 China; 3.4.3.1.1 China Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.4.3.1.2 China Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.4.3.2 Japan; 3.4.3.2.1 Japan Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.4.3.2.2 Japan Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.4.3.3 South Korea; 3.4.3.3.1 South Korea Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.4.3.3.2 South Korea Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.4.3.4 India; 3.4.3.4.1 India Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.4.3.4.2 India Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.4.3.5 Indonesia; 3.4.3.5.1 Indonesia Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.4.3.5.2 Indonesia Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.4.3.6 Rest of Asia; 3.4.3.6.1 Rest of Asia Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.4.3.6.2 Rest of Asia Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.5. Rest of World; 3.5.1 Rest of World Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.5.2 Rest of World Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.5.3 Rest of World Acute Myeloid Leukemia Therapeutics Market, By Country; 3.5.3.1 Brazil; 3.5.3.1.1 Brazil Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.5.3.1.2 Brazil Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.5.3.2 Mexico; 3.5.3.2.1 Mexico Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.5.3.2.2 Mexico Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.5.3.3 South Africa; 3.5.3.3.1 South Africa Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.5.3.3.2 South Africa Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.5.3.4 Australia; 3.5.3.4.1 Australia Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.5.3.4.2 Australia Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; 3.5.3.5 RoW Countries; 3.5.3.5.1 RoW Countries Acute Myeloid Leukemia Therapeutics Market, By Drug Class; 3.5.3.5.2 RoW Countries Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel; RoW Countries Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD LIST OF TABLES; TABLE 1. Global Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 2. Chemotherapy Market Value, By Region, 2022-2031, Million USD; TABLE 3. North America Chemotherapy Market Value, By Country, 2022-2031, Million USD; TABLE 4. Europe Chemotherapy Market Value, By Country, 2022-2031, Million USD; TABLE 5. Asia-Pacific Chemotherapy Market Value, By Country, 2022-2031, Million USD; TABLE 6. Rest of World Chemotherapy Market Value, By Country, 2022-2031, Million USD; TABLE 7. Targeted Therapy and Immunotherapy Market Value, By Region, 2022-2031, Million USD; TABLE 8. North America Targeted Therapy and Immunotherapy Market Value, By Country, 2022-2031, Million USD; TABLE 9. Europe Targeted Therapy and Immunotherapy Market Value, By Country, 2022-2031, Million USD; TABLE 10. Asia-Pacific Targeted Therapy and Immunotherapy Market Value, By Country, 2022-2031, Million USD; TABLE 11. Rest of World Targeted Therapy and Immunotherapy Market Value, By Country, 2022-2031, Million USD; TABLE 12. Global Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 13. Hospital Pharmacies Market Value, By Region, 2022-2031, Million USD; TABLE 14. North America Hospital Pharmacies Market Value, By Country, 2022-2031, Million USD; TABLE 15. Europe Hospital Pharmacies Market Value, By Country, 2022-2031, Million USD; TABLE 16. Asia-Pacific Hospital Pharmacies Market Value, By Country, 2022-2031, Million USD; TABLE 17. Rest of World Hospital Pharmacies Market Value, By Country, 2022-2031, Million USD; TABLE 18. Drug Stores and Retail Pharmacies Market Value, By Region, 2022-2031, Million USD; TABLE 19. North America Drug Stores and Retail Pharmacies Market Value, By Country, 2022-2031, Million USD; TABLE 20. Europe Drug Stores and Retail Pharmacies Market Value, By Country, 2022-2031, Million USD; TABLE 21. Asia-Pacific Drug Stores and Retail Pharmacies Market Value, By Country, 2022-2031, Million USD; TABLE 22. Rest of World Drug Stores and Retail Pharmacies Market Value, By Country, 2022-2031, Million USD; TABLE 23. Online Provides Market Value, By Region, 2022-2031, Million USD; TABLE 24. North America Online Provides Market Value, By Country, 2022-2031, Million USD; TABLE 25. Europe Online Provides Market Value, By Country, 2022-2031, Million USD; TABLE 26. Asia-Pacific Online Provides Market Value, By Country, 2022-2031, Million USD; TABLE 27. Rest of World Online Provides Market Value, By Country, 2022-2031, Million USD; TABLE 28. Global Acute Myeloid Leukemia Therapeutics Market Value, By Region, 2022-2031, Million USD; TABLE 29. North America Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 30. North America Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 31. North America Acute Myeloid Leukemia Therapeutics Market Value, By Country, 2022-2031, Million USD; TABLE 32. U.S. Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 33. U.S. Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 34. Canada Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 35. Canada Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 36. Europe Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 37. Europe Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 38. Europe Acute Myeloid Leukemia Therapeutics Market Value, By Country, 2022-2031, Million USD; TABLE 39. Germany Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 40. Germany Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 41. U.K. Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 42. U.K. Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 43. France Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 44. France Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 45. Italy Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 46. Italy Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 47. Spain Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 48. Spain Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 49. Rest of Europe Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 50. Rest of Europe Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 51. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 52. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 53. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Value, By Country, 2022-2031, Million USD; TABLE 54. China Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 55. China Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 56. Japan Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 57. Japan Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 58. South Korea Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 59. South Korea Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 60. India Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 61. India Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 62. Indonesia Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 63. Indonesia Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 64. Rest of Asia Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 65. Rest of Asia Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 66. Rest of World Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 67. Rest of World Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 68. Rest of World Acute Myeloid Leukemia Therapeutics Market Value, By Country, 2022-2031, Million USD; TABLE 69. Brazil Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 70. Brazil Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 71. Mexico Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 72. Mexico Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 73. South Africa Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 74. South Africa Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 75. Australia Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 76. Australia Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 77. RoW Countries Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD; TABLE 78. RoW Countries Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD; RoW Countries Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD